Literature DB >> 3891167

Studies on fibronectin in inflammatory vs non-inflammatory polymorphonuclear leucocytes of patients with rheumatoid arthritis. I. Immunofluorescent and flow cytometric analysis.

A D Beaulieu, M Audette, C Menard, C Parent, M Duval.   

Abstract

Using indirect immunofluorescence and flow cytometry, we studied the reactivity of an antibody to human fibronectin with human polymorphonuclear leucocytes (PMNL). Our main objective was to compare the intensity of reaction of this antibody with inflammatory vs non-inflammatory PMNL. We used peripheral blood PMNL as a source of non-inflammatory cells and PMNL isolated from the synovial fluid of patients with rheumatoid arthritis as a source of inflammatory cells. Our findings revealed considerably brighter staining of the inflammatory PMNL. Using flow cytometry as a method of measurement, a difference in fluorescence intensity of at least 40 channels (log scale) was observed in all 12 patients studied when comparing peripheral blood with synovial fluid PMNL. In inflammatory PMNL, fibronectin was found both at the intracellular and membrane levels of the cell whereas fibronectin could be detected only intracellularly in non-inflammatory PMNL.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891167      PMCID: PMC1577036     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Neutrophils synthesize and deposit fibronectin on surfaces to which they attach.

Authors:  G Weissmann; E Pearlstein; H D Perez; S Falkow; I M Goldstein; S T Hoffstein
Journal:  Trans Assoc Am Physicians       Date:  1980

3.  Different molecular forms of fibronectin in rheumatoid synovial fluid.

Authors:  I Clemmensen; R B Andersen
Journal:  Arthritis Rheum       Date:  1982-01

4.  The influence of fibronectin on cryoprecipitate formation in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  A D Beaulieu; J P Valet; J Strevey
Journal:  Arthritis Rheum       Date:  1981-11

5.  Significance of fibronectin in rheumatoid arthritis and osteoarthrosis.

Authors:  D L Scott; A C Wainwright; K W Walton; N Williamson
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

6.  Augmentation of human monocyte opsonin-independent phagocytosis by fragments of human plasma fibronectin.

Authors:  J K Czop; J L Kadish; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

7.  Fibonectin is a component of the surface coat of human neutrophils.

Authors:  S T Hoffstein; G Weissmann; E Pearlstein
Journal:  J Cell Sci       Date:  1981-08       Impact factor: 5.285

8.  Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes.

Authors:  M P Bevilacqua; D Amrani; M W Mosesson; C Bianco
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

9.  Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment.

Authors:  A E Postlethwaite; J Keski-Oja; G Balian; A H Kang
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

10.  Fibronectin is produced by human macrophages.

Authors:  K Alitalo; T Hovi; A Vaheri
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

View more
  2 in total

1.  Monocyte subsets in the production of inhibitory factor by Candida albicans-activated human T cells.

Authors:  G Lombardi; E Piccolella; D Vismara; V Colizzi; M Zembala
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

2.  Studies on fibronectin in inflammatory vs non-inflammatory polymorphonuclear leucocytes of patients with rheumatoid arthritis. II. Synthesis and release of fibronectin in vitro.

Authors:  C Menard; A D Beaulieu; M Audette; J Corbeil; L Latulippe
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.